Thrombelastographic investigation of the therapy of a dilutional coagulopathy with fibrinogen and factor XIII
- Conditions
- dilutional coagulopathy
- Registration Number
- DRKS00016699
- Lead Sponsor
- Justus-Liebig-Universität Gießen Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
age > 18 years
- patentes informed consent
- no severe diseases in patients history (malignancies, cardiovascular and respiratory disorders)
- pat. should feel fine before blood donation
- no coagulatory disorders in patients history
Exclusion Criteria
- exclusion criteria in accordance to the general exclusion criteria for blood donation of the clinic for transfusion medicine
- need for anticoagulative medication
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference of Clotting Time and Mean Clot Firmness time after treatment of the dilutional coagulopathy
- Secondary Outcome Measures
Name Time Method Difference of activity of the coagulatory factors (Fibrinogen, V, VIII, XI) as well as of the Clotting Time und Mean Clot Firmness Time after thawing.